FTO and metabolic dysfunction-associated steatotic liver disease: FTO (R316A) mutant lacks demethylation function and is unable to modulate mitochondrial and TG levels, the level of FTO is enhanced in the hepatic tissue of NAFLD patients who are hyperglycemic and hyperinsulinemic.